SEC Form 4 · accession 0001209191-18-021664
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sonja Nelson
Officer — Chief Accounting Officer
Period of report
Mar 23, 2018
Accepted (ET)
Mar 26, 2018 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 23, 2018 | M | 15,000 | $0.00 | A | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1 | — | Mar 23, 2018 | M | 15,000 | D | — | — | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 50% of the RSUs vested on March 23, 2018, and the remaining 50% of the RSUs will vest on March 23, 2020.
- F2Each restricted stock unit represents a contingent right to receive one share of NantKwest, Inc. common stock.